2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Uterine Cervical Dysplasia
2
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Rectal Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Esophageal Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma in Situ
1
Carcinoma
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
Paclitaxel
328
Carboplatin
323
Bevacizumab
171
Gemcitabine
106
liposomal doxorubicin
104
pembrolizumab
101
Cyclophosphamide
96
Topotecan
94
olaparib
92
Cisplatin
92
niraparib
69
Docetaxel
57
Taxes
52
Doxorubicin
51
Drug Therapy
45
fludarabine
40
Filgrastim
39
Nivolumab
37
Magnetic Resonance Spectroscopy
34
Surveys and Questionnaires
33
Specimen Handling
33
Etoposide
32
Hyperthermic Intraperitoneal Chemotherapy
31
Blood Specimen Collection
29
Immunoglobulin G
27
Disulfides
27
Peripheral Blood Stem Cell Transplantation
26
Cytoreduction Surgical Procedures
25
Albumin-Bound Paclitaxel
25
durvalumab
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Indomethacin
×
Clear all
NCT01719926
2026-06-04
PIFA
UMC Utrecht
Phase 1
Completed
13 enrolled